Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,288 | -12,600 | -10,144 | -7,172 | -3,933 |
| Depreciation Amortization | 5 | 22 | 16 | 11 | 5 |
| Accounts payable and accrued liabilities | 33 | -647 | -716 | -162 | -72 |
| Other Working Capital | 432 | -929 | -261 | 63 | 126 |
| Other Operating Activity | 61 | 1,259 | 1,171 | 498 | 242 |
| Operating Cash Flow | $-2,757 | $-12,894 | $-9,933 | $-6,762 | $-3,631 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35,099 | 5,048 | 834 | 459 | 59 |
| Other Financing Activity | -475 | -408 | -36 | -18 | -3 |
| Financing Cash Flow | $34,624 | $4,640 | $799 | $441 | $56 |
| Exchange Rate Effect | 0 | 5 | 3 | 4 | 1 |
| Beginning Cash Position | 14,641 | 22,890 | 22,890 | 22,890 | 22,890 |
| End Cash Position | 46,508 | 14,641 | 13,759 | 16,573 | 19,316 |
| Net Cash Flow | $31,867 | $-8,254 | $-9,131 | $-6,317 | $-3,575 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,757 | -12,894 | -9,933 | -6,762 | -3,631 |
| Free Cash Flow | -2,757 | -12,894 | -9,933 | -6,762 | -3,631 |